ACM
Altium Capital Management’s Larimar Therapeutics LRMR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-273,204
| Closed | -$587K | – | 9 |
|
|
2025
Q1 | $587K | Sell |
273,204
-231,796
| -46% | -$498K | 1.42% | 14 |
|
|
2024
Q4 | $1.95M | Sell |
505,000
-188,000
| -27% | -$728K | 0.55% | 45 |
|
|
2024
Q3 | $4.54M | Hold |
693,000
| – | – | 1.34% | 27 |
|
|
2024
Q2 | $5.02M | Sell |
693,000
-2,000
| -0.3% | -$14.5K | 2.05% | 20 |
|
|
2024
Q1 | $5.28M | Buy |
+695,000
| New | +$5.28M | 2.09% | 17 |
|
|
2022
Q4 | – | Sell |
-320,000
| Closed | -$1.02M | – | 113 |
|
|
2022
Q3 | $1.02M | Buy |
+320,000
| New | +$1.02M | 0.38% | 74 |
|
|
2021
Q2 | – | Sell |
-93,261
| Closed | -$1.36M | – | 147 |
|
|
2021
Q1 | $1.36M | Hold |
93,261
| – | – | 0.38% | 95 |
|
|
2020
Q4 | $2M | Buy |
+93,261
| New | +$2M | 0.75% | 63 |
|